Inactive Instrument

Calendar Cocrystal Pharma Inc OTC Bulletin Board

Equities

US19188J1025

Chart calendar Cocrystal Pharma Inc

23e75937bb77372089a2.s0Cm2qyq6Hge8NpYgX2XaaMVPCT7pKdx_bcKZbi2DgE.9gLlqf_Njit_spIy9Ej8EMVwRUjWkPRAm9t8NYiHXnbYbdyV_MGfFV-Cgw~f9e3300bc02699fa3e9e6eddc01dbac9

Upcoming events on Cocrystal Pharma Inc

25/06/2024 08:30 pm Annual General Meeting
12/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
07/04/2025 Q4 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Cocrystal Pharma Inc

13/05/2024 05:30 pm Q1 2024 Earnings Release
28/03/2024 05:30 pm Q4 2023 Earnings Release
05/12/2023 12:00 am Noble Capital Markets Emerging Growth Equity Conference
27/11/2023 World Vaccine Congress
16/11/2023 Channelchek C-Suite Interview Series
13/11/2023 06:30 pm Q3 2023 Earnings Release
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
14/08/2023 05:30 pm Q2 2023 Earnings Release
08/06/2023 11:30 pm Annual General Meeting
15/05/2023 05:30 pm Q1 2023 Earnings Release
04/05/2023 11:35 pm International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Conference
29/03/2023 08:00 pm Investor Summit
29/03/2023 05:30 pm Q4 2022 Earnings Release
02/02/2023 10:00 pm Sequire Biotechnology Conference
01/02/2023 Channelchek Takeaway Series - The J.P.Morgan Healthcare Conference
01/12/2022 09:40 pm World Antiviral Congress
14/11/2022 10:00 pm FY Investor Summit
14/11/2022 06:30 pm Q3 2022 Earnings Release
03/11/2022 11:35 pm BioFlorida Conference
27/10/2022 04:00 am LD Micro Main Event Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
2,01
2,08
-3.06%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
-19,7
-

-20,6

EBIT
Million USD
Released
Forecast
Spread
-8,87
-9,14
3.02%
-9,59
-11,0
13.13%
-14,2
-14,4
1.37%
-38,8
-40,1
3.23%
-18,6
-19,8
6.07%

-21,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-14,2
-14,4
1.49%
-38,8
-40,1
3.24%
-18,0
-19,2
6.55%

-20,7

Net income
Million USD
Released
Forecast
Spread
-48,2
-6,19
-678.43%
-9,65
-10,7
9.83%
-14,2
-14,4
1.49%
-38,8
-40,1
3.24%
-18,0
-19,2
6.55%

-20,7

EPS
USD
Released
Forecast
Spread
-18,1
-2,28
-694.74%
-2,04
-2,40
15%
-1,92
-1,92
0%
-4,77
-4,93
3.25%
-1,87
-2,09
10.67%

-2,02

Announcement Date27/03/2017/03/2123/03/2229/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,63
-
0,00
0,08
-
0,00
0,08
-
0,00
0,00
-
0,00
0,17
-
0,00
0,27
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-4,21
-3,50
-20.14%
-3,74
-4,20
11.05%
-5,69
-4,10
-38.88%
-4,50
-5,80
22.38%
-5,11
-4,50
-13.58%
-5,20
-5,30
1.91%
-4,44
-4,60
3.41%
-4,67
-5,88
20.65%
-4,16
-5,55
25.08%

-5,20


-5,60


-6,03







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4,21
-3,50
-20.23%
-24,4
-4,20
-481.62%
-5,70
-4,10
-39.02%
-4,50
-5,80
22.4%
-5,19
-4,50
-15.31%
-5,03
-5,30
5.17%
-4,17
-4,60
9.46%
-4,46
-5,88
24.08%
-3,96
-5,50
28.07%

-5,15


-5,55


-5,98







Net income
Million USD
Released
Forecast
Spread
-4,21
-3,50
-20.23%
-24,4
-4,20
-481.62%
-5,70
-4,10
-39.02%
-4,50
-5,80
22.4%
-5,19
-4,50
-15.31%
-5,03
-5,30
5.17%
-4,17
-4,60
9.46%
-4,46
-5,88
24.08%
-3,96
-5,50
28.07%

-5,15


-5,55


-5,98







EPS
USD
Released
Forecast
Spread
-0,48
-0,48
0%
-3,00
-0,54
-455.56%
-0,70
-0,49
-42.86%
-0,54
-0,71
23.94%
-0,64
-0,59
-8.47%
-0,50
-0,53
4.76%
-0,41
-0,53
22.64%
-0,44
-0,60
26.26%
-0,39
-0,54
27.78%

-0,51


-0,55


-0,59


-0,63


-0,45

Announcement Date11/05/2215/08/2214/11/2229/03/2315/05/2314/08/2313/11/2328/03/2413/05/24-----
  1. Stock Market
  2. Equities
  3. COCP Stock
  4. Stock
  5. Calendar Cocrystal Pharma Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW